Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      A Clinical Trial of PRAX-222 in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy
      Description

      The goal of this trial is to learn about the effect of PRAX-222 in pediatric participants with early onset SCN2A developmental and epileptic encephalopathy (DEE), aged 2 to 18 years.

      Conditions
      SCN2A-DEEEpilepsy
      Talk to us
      COMPLETED
      A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
      Description

      This prospective observational study is designed to assess the individualized baseline disease burden in pediatric participants aged 1 year to 16 years, with early-onset SCN2A-DEE by characterizing and quantifying changes in clinical features over a period of up to 12 months.

      Conditions
      SCN2A-DEEEpilepsy
      Talk to us